Submission Details
| 510(k) Number | K070628 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 07, 2007 |
| Decision Date | May 01, 2007 |
| Days to Decision | 55 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
K070628 is an FDA 510(k) clearance for the OPTIMUM GP (ROFLUFOCON A,B,C,D&E) DAILY WEAR CONTACT LENS., a Lens, Contact (other Material) - Daily (Class II — Special Controls, product code HQD), submitted by Contamac, Ltd. (Grand Junction, US). The FDA issued a Cleared decision on May 1, 2007, 55 days after receiving the submission on March 7, 2007. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 886.5916.
| 510(k) Number | K070628 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 07, 2007 |
| Decision Date | May 01, 2007 |
| Days to Decision | 55 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
| Product Code | HQD — Lens, Contact (other Material) - Daily |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 886.5916 |